Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study

PURPOSE: This nationwide retrospective study was conducted to evaluate the efficacy and safety of combined gemcitabine and docetaxel (GD) as an off-label therapy for advanced soft tissue sarcoma, which has limited treatment options owing to its rare occurrence. MATERIALS AND METHODS: A total of 228...

詳細記述

保存先:
書誌詳細
出版年:Cancer Res Treat
主要な著者: Choi, Yunjung, Yun, Mi Sun, Lim, Sang Hee, Lee, Jeeyun, Ahn, Jin-Hee, Kim, Yu Jung, Park, Kyong Hwa, Park, Young Suk, Lim, Ho Yeong, An, Hyonggin, Suh, Dong-Churl, Kim, Yeul Hong
フォーマット: Artigo
言語:Inglês
出版事項: Korean Cancer Association 2018
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5784639/
https://ncbi.nlm.nih.gov/pubmed/28361521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.535
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料